Nanoparticles Mediated circROBO1 Silencing to Inhibit Hepatocellular Carcinoma Progression by Modulating miR-130a-5p/CCNT2 Axis
Hongyu Meng,Ruixi Li,Yuankang Xie,Zhaohong Mo,Hang Zhai,Guangquan Zhang,Guohui Liang,Xianjie Shi,Boxuan Zhou
DOI: https://doi.org/10.2147/ijn.s399318
IF: 7.033
2023-03-31
International Journal of Nanomedicine
Abstract:Hongyu Meng, 1, 2, &ast Ruixi Li, 3, &ast Yuankang Xie, 1, &ast Zhaohong Mo, 2 Hang Zhai, 2 Guangquan Zhang, 3 Guohui Liang, 4 Xianjie Shi, 3 Boxuan Zhou 1, 2 1 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Gannan Medical University, Ganzhou, People's Republic of China; 2 Department of Hepatobiliary Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China; 3 Department of Hepatobiliary and Pancreatic Surgery, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, People's Republic of China; 4 School of Clinical Medicine, Henan University, Kaifeng, People's Republic of China &astThese authors contributed equally to this work Correspondence: Boxuan Zhou; Xianjie Shi, Email ; Background: Circular RNAs (circRNAs) are becoming vital biomarkers and therapeutic targets for malignant tumors due to their high stability and specificity in tissues. However, biological functions of circRNAs in hepatocellular carcinoma (HCC) are still not well studied. Methods: Gene Expression Omnibus (GEO) database and qRT-PCR were used to evaluate expression of circROBO1 (hsa_circ_0066568) in HCC tissues and cell lines. CCK-8, colony formation, EdU staining, flow cytometry for cell cycle analysis, and xenograft model assays were performed to detect the circROBO1 function in vitro and in vivo. RNA pull-down, RNA immunoprecipitation (RIP), and Luciferase reporter assays were used to investigate the relationship among circROBO1, miR-130a-5p, and CCNT2. More importantly, we developed nanoparticles made from poly lactic-co-glycolic acid (PLGA) and polyethylene glycol (PEG) chains as the delivery system of si-circROBO1 and then applied them to HCC in vitro and in mice. Results: circROBO1 was obviously upregulated in HCC tissues and cell lines, and elevated circROBO1 was closely correlated with worse prognosis for HCC patients. Functionally, knocking down circROBO1 significantly suppressed HCC cells growth in vitro and in mice. Mechanistically, circROBO1 acted as a competing endogenous RNA to downregulate miR-130a-5p, leading to CCNT2 expression upregulation. Furthermore, miR-130a-5p mimic or CCNT2 knockdown reversed the role of circROBO1 overexpression on HCC cells, which demonstrated that circROBO1 promoted HCC development via miR-130a-5p/CCNT2 axis. In addition, we developed nanoparticles loaded with si-circROBO1, named as PLGA-PEG (si-circROBO1) NPs, which significantly prevented the proliferation of HCC cells, and did not exhibit apparent toxicity to major organs in vivo. Conclusion: Our findings firstly demonstrate that circROBO1 overexpression promotes HCC progression by regulating miR-130a-5p/CCNT2 axis, which may serve as an effective nanotherapeutic target for HCC treatment. Keywords: nanoparticles, hepatocellular carcinoma, circROBO1, cell proliferation, drug delivery The HCC, a major pathohistological subtype of primary liver cancer, is one of main cause for cancer-associated death in many countries. 1 Generally, HCC patients are asymptomatic at the early stage, when patients diagnosed with HCC at the advanced stage are usually ineligible for therapeutic surgery. 2 Additionally, although survival time in some HCC patients who meet the surgical requirement could be improved, their 5-year overall survival rates remain to be unsatisfactory (about 50%). 3 Hence, it is urgent to identify novel biomarkers to enhance the early diagnosis rate and overall survival (OS) of HCC patients. CircRNAs have been identified involved in the development of various types of cancers, comprising lung cancer, breast cancer, and HCC. 4 CircRNAs form a special covalently closed-loop structure, thus endowing circRNAs more stable character than their linear transcripts from the host gene. Recently, mounting evidence has revealed that this kind of RNAs might adjust gene expression at three different levels: transcriptional, post-transcriptional, and translational level, respectively. 5,6 Circular exonic RNAs which mainly accumulate in cytoplasm may play the role of miRNA sponges to lower their expression, ultimately leading to enhanced expression of these miRNA target genes. 5,7,8 However, circular intronic RNAs or exon-intron RNAs usually appear in the nucleus and can adjust the transcription process. 9 These findings indicate that circRNAs may be involved in different pathological processes. Accumulating studies have demonstrated that circRNAs were deregulated in HCC tissues and regulated the malignant behavior of tumor c -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology